518 results on '"Aust, Gabriela"'
Search Results
202. Expression und Regulation von CD90 (Thy-1) auf makrovaskulären Endothelzellen
- Author
-
Aust, Gabriela, Universität Leipzig, Uptaite, Migle, Aust, Gabriela, Universität Leipzig, and Uptaite, Migle
- Abstract
Das humane CD90 (Thy-1), ein membrangebundenes Glykoprotein, wird auf der Oberfläche von aktivierten mikrovaskulären Endothelzellen (EC), Fibroblasten, Nervenzellen und einer Subpopulation von CD34+ hämatopoetischen Stammzellen exprimiert. CD90 fungiert als Adhäsionsmolekül auf aktivierten mikrovaskulären EC, indem es die Bindung von Leukozyten über die Interaktion mit dem Integrin alfambeta2 (Mac-1, CD11b/CD18) oder dem Adhäsions-GPCR CD97 an das Endothel vermittelt. Die Expression von CD90 auf mikrovaskulären EC wurde sowohl in-vitro als auch in-vivo nachgewiesen. Zur Expression von CD90 auf makrovaskulären EC gibt es nur wenige und sich zum Teil widersprechende in-vitro Daten. In-situ konnte die Expression von CD90 auf diesen Zellen bisher nicht gezeigt werden. Die Atherosklerose ist ein stufenweise verlaufendes chronisch-entzündliches Geschehen in den arteriellen Gefäßen. In der vorliegenden Arbeit wurde in atherosklerotisch-veränderten Gefäßen die Expression von CD90 auf humanen makrovaskulären EC in-situ demonstriert. Dabei wurden neben Operationspräparaten von Patienten mit einer Stenose der A. carotis interna, die entsprechend der American Heart Association Klassifikation die höchsten Atherosklerosestadien zeigen, auch Gefäßtransplantate von Organspendern, die meist nur eine geringe Ausprägung der Atherosklerose aufwiesen, untersucht. CD90 wurde in jedem Atherosklerosestadium auf EC nachgewiesen. Eine signifikante Zunahme der CD90 Expression in höheren Atherosklerosestadien konnte gezeigt werden. Die histologischen Merkmale der Plaque, wie Verkalkung, Blutung, Plaqueruptur oder Thrombusformation korrelieren nicht mit der CD90 Expression. Ein statistisch signifikanter Zusammenhang zwischen symptomatischer und asymptomatischer A.carotis interna-Stenose konnte bezüglich der CD90 Expression auf makrovaskulären EC ebenfalls nicht nachgewiesen werden. Weiterhin sollte mittels Stimulationsversuchen in-vitro geklärt werden, wie die CD90 Expression auf makrovaskuläre
- Published
- 2013
203. Transcriptional regulation of the human CD97 promoter by Sp1/Sp3 in smooth muscle cells
- Author
-
Wobus, Manja, Wandel, Elke, Prohaska, Sonja, Findeiß, Sven, Tschöp, Katrin, Aust, Gabriela, Wobus, Manja, Wandel, Elke, Prohaska, Sonja, Findeiß, Sven, Tschöp, Katrin, and Aust, Gabriela
- Abstract
The EGF-TM7 receptor CD97 shows different features of expression and function in muscle cells compared to hematopoetic and tumor cells. Since the molecular function and regulation of CD97 are poorly understood, this study aimed at defining its basal transcriptional regulation in smooth muscle cells (SMCs). The computational analysis of the CD97 5′-flanking region revealed that the TATA box-lacking promoter possesses several GC-rich regions as putative Sp1/Sp3 binding sites. Transfection studies with serially deleted promoter constructs demonstrated that the minimal promoter fragment resided in the − 218/+ 45 region containing one out of five identified GC-boxes in the leiomyosarcoma cell line SK-LMS-1 and human bronchial smooth muscle cells (HbSMCs). Mutation of the most proximal GC-site in CD97 reporter gene constructs caused a significant decrease in promoter activity. Gel shift assays and chromatin immunoprecipitation revealed that Sp1 and Sp3 bound specifically to the most proximal GC-site. Furthermore, we showed that Sp1 and Sp3 over-expression activates CD97 promoter activity in HEK293 cells. Our data characterize for the first time the activity of the human CD97 promoter which is controlled by Sp1/Sp3 transcription factors in SMCs.
- Published
- 2008
204. Mice overexpressing CD97 in intestinal epithelial cells provide a unique model for mammalian postnatal intestinal cylindrical growth
- Author
-
Aust, Gabriela, primary, Kerner, Christiane, additional, Gonsior, Susann, additional, Sittig, Doreen, additional, Schneider, Hartmut, additional, Buske, Peter, additional, Scholz, Markus, additional, Dietrich, Norman, additional, Oldenburg, Sindy, additional, Karpus, Olga N., additional, Galle, Jörg, additional, Amasheh, Salah, additional, and Hamann, Jörg, additional
- Published
- 2013
- Full Text
- View/download PDF
205. Combined spectrophotometry and tensile measurements of human connective tissues: potentials and limitations
- Author
-
Ernstberger, Markus, primary, Sichting, Freddy, additional, Baselt, Tobias, additional, Hartmann, Peter, additional, Aust, Gabriela, additional, and Hammer, Niels, additional
- Published
- 2013
- Full Text
- View/download PDF
206. Sticky Signaling—Adhesion Class G Protein–Coupled Receptors Take the Stage
- Author
-
Langenhan, Tobias, primary, Aust, Gabriela, additional, and Hamann, Jörg, additional
- Published
- 2013
- Full Text
- View/download PDF
207. Thy-1 (CD90) Is an Interacting Partner for CD97 on Activated Endothelial Cells
- Author
-
Wandel, Elke, primary, Saalbach, Anja, additional, Sittig, Doreen, additional, Gebhardt, Carl, additional, and Aust, Gabriela, additional
- Published
- 2012
- Full Text
- View/download PDF
208. Highly selective A1-adenosine-agonist (2-chloro-N6-cyclopentyladenosine) and reduction of flap necrosis in adipocutaneous flaps in rats
- Author
-
Dacho, Andreas K., primary, Lyutenski, Stefan, additional, Aust, Gabriela, additional, and Dietz, Andreas, additional
- Published
- 2011
- Full Text
- View/download PDF
209. A Comprehensive Model of the Spatio-Temporal Stem Cell and Tissue Organisation in the Intestinal Crypt
- Author
-
Buske, Peter, primary, Galle, Jörg, additional, Barker, Nick, additional, Aust, Gabriela, additional, Clevers, Hans, additional, and Loeffler, Markus, additional
- Published
- 2011
- Full Text
- View/download PDF
210. Overexpression of CD97 in Intestinal Epithelial Cells of Transgenic Mice Attenuates Colitis by Strengthening Adherens Junctions
- Author
-
Becker, Susann, primary, Wandel, Elke, additional, Wobus, Manja, additional, Schneider, Rick, additional, Amasheh, Salah, additional, Sittig, Doreen, additional, Kerner, Christiane, additional, Naumann, Ronald, additional, Hamann, Joerg, additional, and Aust, Gabriela, additional
- Published
- 2010
- Full Text
- View/download PDF
211. Analysis of CD97 Expression and Manipulation: Antibody Treatment but Not Gene Targeting Curtails Granulocyte Migration
- Author
-
Veninga, Henrike, primary, Becker, Susann, additional, Hoek, Robert M., additional, Wobus, Manja, additional, Wandel, Elke, additional, van der Kaa, Jos, additional, van der Valk, Martin, additional, de Vos, Alex F., additional, Haase, Hannelore, additional, Owens, Bronwyn, additional, van der Poll, Tom, additional, van Lier, René A. W., additional, Verbeek, J. Sjef, additional, Aust, Gabriela, additional, and Hamann, Jörg, additional
- Published
- 2008
- Full Text
- View/download PDF
212. Transcriptional regulation of the human CD97 promoter by Sp1/Sp3 in smooth muscle cells
- Author
-
Wobus, Manja, primary, Wandel, Elke, additional, Prohaska, Sonja, additional, Findeiβ, Sven, additional, Tschöp, Katrin, additional, and Aust, Gabriela, additional
- Published
- 2008
- Full Text
- View/download PDF
213. Diversity of common alternative splicing variants of human cytochrome P450 1A1 and their association to carcinogenesis
- Author
-
Bauer, Mario, primary, Herbarth, Olf, additional, Rudzok, Susanne, additional, Schmücking, Eike, additional, Müller, Andrea, additional, Aust, Gabriela, additional, and Gräbsch, Carolin, additional
- Published
- 2007
- Full Text
- View/download PDF
214. Particle-Mediated Cytokine Gene Therapy Leads to Antitumor and Antimetastatic Effects in Mouse Carcinoma Models
- Author
-
Dietrich, Arne, primary, Becherer, Lars, additional, Brinckmann, Ute, additional, Hauss, Johann, additional, Liebert, Uwe G., additional, Gütz, Anke, additional, and Aust, Gabriela, additional
- Published
- 2006
- Full Text
- View/download PDF
215. CD97: A dedifferentiation marker in human thyroid carcinomas
- Author
-
Aust, Gabriela, Eichler, Wolfram, Laue, Sandy, Lehmann, Irina, Heldin, Nils-Erik, Lotz, Oliver, Scherbaum, Werner A., Dralle, Henning, Hoang-Vu, Cuong, Aust, Gabriela, Eichler, Wolfram, Laue, Sandy, Lehmann, Irina, Heldin, Nils-Erik, Lotz, Oliver, Scherbaum, Werner A., Dralle, Henning, and Hoang-Vu, Cuong
- Abstract
CD97 is a dimeric glycoprotein of Mr 75,000-85,000 and 28,000 belonging to a novel subfamily of seven-span transmembrane region leukocyte cell surface molecules. It is expressed abundantly in cells of hematopoietic origin. This is the first report demonstrating the expression of CD97 outside the hematopoetic system. CD97 was studied in normal human and neoplastic follicular epithelium of the thyroid and anaplastic (n = 3) and papillary (n = 1) thyroid carcinoma cell lines. In normal thyroid tissue (n = 11), no immunoreactivity of CD97 could be found, whereas in differentiated thyroid carcinomas (n = 10), CD97 expression was either lacking or low. Eleven of 12 undifferentiated anaplastic carcinomas revealed high CD97 presentation. CD97 was absent or only weakly present in patients with postoperative T1 tumors but increased greatly with the progression to postoperative T4 tumors. CD97 is clearly present in thyroid carcinoma cell lines but only at a very low level in normal human thyrocytes. Quantitation of CD97 cell surface expression levels revealed that C 643 and SW 1736 cells showed a two to four times higher specific antibody-binding capacity than did 8505 C and HTh 74 cells and a nearly 20 times higher specific antibody-binding capacity than normal thyrocytes. Phorbol 12-myristate 13-acetate treatment progressively caused a decrease of CD97 antigen expression in all cell lines to about 30% of their initial levels after 48 h. Immunohistochemical staining of SW 1736 cells revealed that CD97 is located in most of the cell compartments and suggested a CD97 internalization process after phorbol 12-myristate 13-acetate treatment. Semiquantitative reverse transcription-PCR showed a correlation of CD97 mRNA and cell surface CD97 expression level in the cell lines. SW 1736, HTh 74, and 8505 C cells apparently expressed CD97 with alternative glycosylation compared to peripheral lymphocytes, whereas most of the CD97 antigen presented on thyrocytes and C 643 cells had glycos
- Published
- 1997
216. CD97, but Not Its Closely Related EGF-TM7 Family Member EMR2, Is Expressed on Gastric, Pancreatic, and Esophageal Carcinomas
- Author
-
Aust, Gabriela, primary, Steinert, Matthias, additional, Schütz, Alexander, additional, Boltze, Carsten, additional, Wahlbuhl, Mandy, additional, Hamann, Jörg, additional, and Wobus, Manja, additional
- Published
- 2002
- Full Text
- View/download PDF
217. Expression of tumour necrosis factor-alpha (TNF-alpha) mRNA and protein in pathological thyroid tissue and carcinoma cells.
- Author
-
Aust, Gabriela, Heuer, M., Laue, S., Lehmann, I., Hofmann, A., Heldin, Nils-Erik, Scherbaum, W.A., Aust, Gabriela, Heuer, M., Laue, S., Lehmann, I., Hofmann, A., Heldin, Nils-Erik, and Scherbaum, W.A.
- Published
- 1996
218. Competitive RT-PCR to Quantify Small Amounts of mRNA.
- Author
-
Walker, John M., De Ley, Marc, and Aust, Gabriela
- Abstract
Monitoring cytokine responses to various stimuli or determining the expression pattern of cytokine mRNAs requires sensitive technologies for cytokine mRNA quantitation where there is a limited quantity of material, for example, when working with biopsies. Owing to their amplifying effect, reverse transcriptase-polymerase chain reacttion (RT-PCR)-based methods permit the analysis of minimal starting quantities of nucleic acids. Because of the exponential nature of PCR, introduction of a competitive internal standard (competitor) has proven to be of great advantage for quantitation. Competitive RT-PCR is capable of ruling out tube-to-tube and sample-to-sample variation, because the competitor and the target of interest are amplified in the same reaction tube, compete for the same enzyme and nucleotides, and, thus, are subjected to identical amplification conditions (1,2). This is achieved by the special construction of the competitor, which bears the same primer-binding regions as the target of interest, but the sequence in between is modified in such a way that amplification products derived from the competitor and the target can be differentiated. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
219. The expression of substance P and its neurokinin-1 receptor mRNA in the bovine corpus luteum of early developmental stage
- Author
-
Reibiger, Ina, primary, Aust, Gabriela, additional, Tscheudschilsuren, Gerelsul, additional, Beyer, Robert, additional, Gebhardt, Claudia, additional, and Spanel-Borowski, Katharina, additional
- Published
- 2001
- Full Text
- View/download PDF
220. Activated and interferon-γ producing thyroid-derived T cells are detected in Graves' disease, thyroid autonomy as well as in non-toxic multinodular goiter
- Author
-
Aust, Gabriela, primary, Lehmann, Irina, additional, Laue, Sandy, additional, and Scherbaum, Werner A, additional
- Published
- 1996
- Full Text
- View/download PDF
221. Different Cytokine mRNA Profiles in Graves' Disease, Hashimoto's Thyroiditis, and Nonautoimmune Thyroid Disorders Determined by Quantitative Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)
- Author
-
HEUER, MARKUS, primary, AUST, GABRIELA, additional, ODE-HAKIM, SUSANNE, additional, and SCHERBAUM, WERNER A., additional
- Published
- 1996
- Full Text
- View/download PDF
222. A novel FoxD3Variant Is Associated With Vitiligo and Elevated Thyroid Auto-Antibodies
- Author
-
Schunter, Jo Ana, Löffler, Dennis, Wiesner, Tobias, Kovacs, Peter, Badenhoop, Klaus, Aust, Gabriela, Tönjes, Anke, Müller, Peter, Baber, Ronny, Simon, Jan C., Führer, Dagmar, Pfäffle, Roland W., Thiery, Joachim, Stumvoll, Michael, Kiess, Wieland, Kratzsch, Jürgen, and Körner, Antje
- Abstract
Context:Vitiligo frequently coincides with autoimmune endocrinopathies, particularly Hashimoto's thyroiditis (HT). Genetic susceptibility may underlie this coincident occurrence. One candidate region is the autoimmunity susceptibility locus on chromosome 1, which encompasses forkhead transcription factor D3 (FoxD3), a gene involved in embryonal melanogenesis. We identified a promotor variant (rs78645479) in an index case of vitiligo + HT + candidiasis and evaluated its clinical and functional relevance.Design:We genotyped 281 patients with variable autoimmune endocrinopathies: HT, Graves' disease (GD), type 1 diabetes (T1D), Addison's disease (AD), autoimmune polyglandular syndrome (APS), and/or vitiligo and 1858 controls. Furthermore, we experimentally assessed the effect of the variant on promotor activity and assessed the expression of FoxD3in human thyroid tissue samples.Results:Patients with vitiligo had a higher frequency of the risk allele (30%) compared with healthy controls (18.2%). In addition, the variant was associated with the incidence of elevated anti-TPO antibodies and anti-Tg antibodies, but not with TSH, FT3, or FT4levels and also not with GD, T1D, AD, or APS. Functionally, the variant increased transcriptional activity in Jurkat and in Hek293 cells. We confirmed gene expression of FoxD3in human thyroid tissue, which seemed elevated in thyroid tissue samples of some patients with GD and nonautoimmune goiter but not in patients with HT.Conclusion:In addition to a possible association of rs78645479 in FoxD3with vitiligo, our data on the association of this FoxD3variant with thyroid autoantibodies suggest a potential involvement of FoxD3 in thyroid immunoregulation.
- Published
- 2015
- Full Text
- View/download PDF
223. Induction of Insulin Antibodies and Insulin Allergy under Alpha-Interferon Treatment of Renal Cell Carcinoma in a Patient with Insulin-Treated Diabetes mellitus – A Case Report
- Author
-
Krug, Jürgen, primary, Fritzsch, Jörg, additional, and Aust, Gabriela, additional
- Published
- 1995
- Full Text
- View/download PDF
224. Dissecting signaling and functions of adhesion G protein-coupled receptors.
- Author
-
Araç, Demet, Aust, Gabriela, Calebiro, Davide, Engel, Felix B., Formstone, Caroline, Goffinet, André, Hamann, Jörg, Kittel, Robert J., Liebscher, Ines, Lin, Hsi‐Hsien, Monk, Kelly R., Petrenko, Alexander, Piao, Xianhua, Prömel, Simone, Schiöth, Helgi B., Schwartz, Thue W., Stacey, Martin, Ushkaryov, Yuri A., Wobus, Manja, and Wolfrum, Uwe
- Subjects
- *
G protein coupled receptors , *CELL adhesion , *CELLULAR signal transduction , *GENOMES , *MOLECULAR structure , *PROTEOLYSIS , *MOLECULAR genetics - Abstract
G protein-coupled receptors (GPCRs) comprise an expanded superfamily of receptors in the human genome. Adhesion class G protein-coupled receptors (adhesion-GPCRs) form the second largest class of GPCRs. Despite the abundance, size, molecular structure, and functions in facilitating cell and matrix contacts in a variety of organ systems, adhesion-GPCRs are by far the most poorly understood GPCR class. Adhesion-GPCRs possess a unique molecular structure, with extended N-termini containing various adhesion domains. In addition, many adhesion-GPCRs are autoproteolytically cleaved into an N-terminal fragment (NTF, NT, α-subunit) and C-terminal fragment (CTF, CT, β-subunit) at a conserved GPCR autoproteolysis-inducing (GAIN) domain that contains a GPCR proteolysis site (GPS). These two features distinguish adhesion-GPCRs from other GPCR classes. Though active research on adhesion-GPCRs in diverse areas, such as immunity, neuroscience, and development and tumor biology has been intensified in the recent years, the general biological and pharmacological properties of adhesion-GPCRs are not well known, and they have not yet been used for biomedical purposes. The '6th International Adhesion-GPCR Workshop,' held at the Institute of Physiology of the University of Würzburg on September 6-8, 2012, assembled a majority of the investigators currently actively pursuing research on adhesion-GPCRs, including scientists from laboratories in Europe, the United States, and Asia. The meeting featured the nascent mechanistic understanding of the molecular events driving the signal transduction of adhesion-GPCRs, novel models to evaluate their functions, and evidence for their involvement in human disease. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
225. Ultimate stress and age-dependent deformation characteristics of the iliotibial tract.
- Author
-
Hammer, Niels, Lingslebe, Uwe, Aust, Gabriela, Milani, Thomas L., Hädrich, Carsten, and Steinke, Hanno
- Subjects
BIOMECHANICS ,DEFORMATIONS (Mechanics) ,LIGAMENTS ,TISSUE mechanics ,PELVIS ,MODULUS of elasticity ,STIFFNESS (Engineering) ,BODY weight - Abstract
Abstract: Background and aims: To understand biomechanics of ligaments and tendons data on their material properties are necessary. The iliotibial tract is a suitable model for virtual pelvic or lower extremity ligaments due to its parallel fibers, which facilitates biomechanical testing. Here, we determined Young''s modulus (YM) as secant stiffness between defined limits of the iliotibial tract and correlated the data to ultimate stress (US) of the specimens and to age, gender and body weight of the body donors. Materials and methods: Thirty eight specimens from 12 iliotibial tracts of 10 young donors (mean age 31.2±9.1 years) were investigated biomechanically. After preconditioning, YM were determined in the ranges of 0–4 and 4–11N/mm² of applied stress and from 4N/mm² of applied stress to US. Results: YM of the specimens were 84.7±30.2 (0–4N/mm²), 335.4±101.9 (4–11N/mm²), and 369.1±191.5 (4N/mm² to US) N/mm², respectively. The mean US was 35.8±16.4N/mm². YM and US correlated closely in the ranges of 4–11N/mm² (r=0.95) and 4N/mm² to US (r=0.91). YM did not correlate to age, body weight or gender within these young donors. Concerning tissue behavior a decrease of YM, i.e. weakening, is more common than an increase of YM, i.e. stiffening, before specimen failure. Overall, YM of specimens from young donors were significantly lower compared to those of old donors. Discussion and conclusions: This is the first study providing age-dependent nonlinear stiffness properties of the iliotibial tract. YM is significantly lower in young than in old donors and is thus a subject of alteration during life time. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
226. Highly selective A1-adenosine-agonist (2-chloro-N6-cyclopentyladenosine) and reduction of flap necrosis in adipocutaneous flaps in rats.
- Author
-
Dacho, Andreas K., Lyutenski, Stefan, Aust, Gabriela, and Dietz, Andreas
- Subjects
ADENOSINES ,FREE flaps ,NECROSIS ,REPERFUSION injury ,MYOCARDIUM ,LABORATORY rats ,THERAPEUTICS ,WOUNDS & injuries - Abstract
Background The 2-chloro-N
6 -cyclopentyladenosine (CCPA) was proven to be a protective factor in ischemic reperfusion injury in myocardium and to reduce the infarct size in the heart. The purpose of this study was to determine whether flap necrosis could be reduced by intravenous administration of CCPA. Methods Fifty-six male Wistar rats were divided into 4 experimental groups. An epigastric adipocutaneous flap was raised, and the area of flap necrosis was assessed for all groups on the fifth postoperative day with planimetry software. Results The control group had a significantly lower rate of flap necrosis than the ischemic control group ( p < .05). The nonischemic CCPA group had a significantly lower rate of flap necrosis than the nonischemic control group ( p < .05). The ischemic CCPA group had a highly significant ( p < .0001) rate of lower flap necrosis than the ischemic control group. Conclusion Our data show that reduction of flap necrosis can be achieved both with and without ischemic periods by intravenous administration of CCPA. © 2011 Wiley Periodicals, Inc. Head Neck, 2011 [ABSTRACT FROM AUTHOR]- Published
- 2012
- Full Text
- View/download PDF
227. Evidence of leptin expression in normal and polycystic human ovaries.
- Author
-
Löffler, Sabine, Aust, Gabriela, Köhler, Uwe, and Spanel-Borowski, Katharina
- Published
- 2001
- Full Text
- View/download PDF
228. Eosinophils in the human corpus luteum: the role of RANTES and eotaxin in eosinophil attraction into periovulatory structures.
- Author
-
Aust, Gabriela
- Abstract
Evaluates the presence and number of eosinophils at varying stages in the human corpus luteum from the ovaries of women at reproductive age. Numbers of extravasated eosinophils at the granulosa layer, thecal layer and hemorrhages in the former antrum; Reduction of eosinophils during secretion and regression stages; Expression and regulation of eosinophil-attracting chemokines RANTES and eotaxin.
- Published
- 2000
- Full Text
- View/download PDF
229. Regulation of the diabetes-associated autoantigen IA-2 in INS-1 pancreatic beta-cells.
- Author
-
Seissler, Jochen, Nguyen, Thi-Bang-Tam, Aust, Gabriela, Steinbrenner, Holger, Scherbaum, Werner A., Seissler, J, Nguyen, T B, Aust, G, Steinbrenner, H, and Scherbaum, W A
- Subjects
GENETIC regulation ,PANCREATIC beta cells ,AUTOIMMUNE diseases - Abstract
IA-2, a member of the protein tyrosine phosphatase family, represents a major target autoantigen in type 1 diabetes. To study the regulation of IA-2 gene expression, we used INS-1 insulinoma cells to analyze beta-cell signal transduction pathways as well as the effect of metabolic and hormonal factors involved in the regulation of the insulin secretory pathway. Quantitative competitive reverse transcriptase-polymerase chain reaction revealed that an increase of cellular cAMP mediated by forskolin (10 micromol/l, 24 h) or 3-isobutyl-1-methylxanthine (100 micromol/l, 24 h) induced maximal stimulation of IA-2 mRNA levels (451 +/- 85 and 338 +/- 86% compared with basal conditions; P < 0.001). In contrast, activation of protein kinase C (PKC) by short-term treatment with phorbol 12-myristate 13-acetate (PMA) (1 micromol/l, 6 h) did not alter IA-2 expression, whereas depletion of PKC by prolonged culturing (24 h) exerted a significant inhibition (57 +/- 24%; P < 0.05). cAMP-dependent upregulation was confirmed by the findings that glucagon (10 micromol/l, 24-48 h) increased levels of IA-2 mRNA (190 +/- 35%; P < 0.05), whereas short-term incubation with high glucose concentration showed no effect. However, prolonged incubation in high glucose (21 mmol/l) induced a time- and dose-dependent increase of IA-2 mRNA expression, reaching maximal values after 144 h (285 +/- 68%; P < 0.05). These studies demonstrate that stimuli of insulin secretion that operate by activation of adenylate cyclase generating cAMP significantly increase IA-2 gene expression. In contrast, activation of PKC by high glucose concentration or PMA exerted no effect, suggesting that IA-2 gene expression is not simply coupled to insulin secretion, but may be involved in the fine regulation of beta-cell function. These findings may be important to clarify the function of IA-2 in beta-cells and elucidate mechanisms involved in the induction of autoimmunity to IA-2. [ABSTRACT FROM AUTHOR]
- Published
- 2000
- Full Text
- View/download PDF
230. Severity-Dependent Long-Term Post-Traumatic Changes in the Circulating Oxylipin Profile.
- Author
-
Reinicke, Madlen, Zheng, Leyu, Rang, Moujie, Fuchs, Carolin, Weikert, Juliane, Keß, Annette, Kleber, Christian, Ceglarek, Uta, Osterhoff, Georg, and Aust, Gabriela
- Abstract
Trauma causes the breakdown of membrane phospholipids and the subsequent degradation of the released polyunsaturated fatty acids (PUFAs) to partially bioactive oxylipins. Here, we screened for circulating PUFAs and oxylipins in patients (n = 34) differing from those of uninjured controls (n = 25) and analyzed their diagnostic potential. Patients were followed up for 1 to 240 h after minor/moderate, severe, and very severe injuries. Of the targeted oxylipins, 13 out of 80 (13/80) were detected in almost all patients and controls. Injury caused a long-term decrease in 9- and 13-hydroxyoctadecadienoic acids and in several dihydroxyeicosatetraenoic acids, the stable derivatives of bioactive anti-inflammatory epoxyeicosatrienoic acids, compared to controls. Frequently, these oxylipins correlated inversely to injury severity, days in the intensive care unit and hospital, and/or procalcitonin and pro-inflammatory cytokine levels 48 up to 240 h after trauma. Notably, 20/80 oxylipins were detected in some patients but not or less often in controls. Many of these oxylipins increased transiently immediately after injury. Their level is partly correlated with adverse clinical parameters at this early time point. The circulating oxylipidome was markedly affected by trauma. Several oxylipins showed injury-dependent alterations at different time points in the post-traumatic course. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
231. Combined spectro-photometry and tensile measurements of human connective tissues: potentials and limitations.
- Author
-
Ernstberger, Markus, Sichting, Freddy, Baselt, Tobias, Hartmann, Peter, Aust, Gabriela, and Hammer, Niels
- Subjects
CONNECTIVE tissues ,SPECTROPHOTOMETRY ,MEASUREMENT of tensile strength ,COLLAGEN ,POLARIZATION microscopy ,STRESS-strain curves - Abstract
Strain-dependent transmission data of nine iliotibial tract specimens are determined using a custom-built optical setup with a halogen light source and an industrial norm material testing machine. Polarized light microscopy and hematoxylin-eosin staining indicated that lateral contraction of collagen structures is responsible for total intensity variations during a 20-cycle preconditioning and a 5-cycle tensile test. Tensile force progress is opposite to total transmission progress. Due to dehydration, wavelength-specific radiation intensity shifting is determined during the test, primarily noticeable in a water absorption band between 1400 and 1500 nm. The results show the capability of integrating spectrophotometry technology into biomechanics for determining structural alterations of human collagen due to applied strain. Being more sensitive to drying, spectrophotometry may likely serve as a quality control in stress-strain testing of biological structures. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
232. Immunologic cellular characteristics of the tumour microenvironment of hepatocellular carcinoma drive patient outcomes.
- Author
-
Atanasov, Georgi, Dino, Karoline, Schierle, Katrin, Dietel, Corinna, Aust, Gabriela, Pratschke, Johann, Seehofer, Daniel, Schmelzle, Moritz, and Hau, Hans-Michael
- Subjects
HEPATOCELLULAR carcinoma ,TUMOR microenvironment ,SURVIVAL analysis (Biometry) ,LYMPHOCYTES ,MONOCYTES ,MACROPHAGES ,CANCER prognosis ,TUMOR markers - Abstract
Background: Anti-tumour immune competence has an impact in hepatocarcinogenesis and success of anti-cancer therapies. Tumour-infiltrating lymphocytes (TILs) and monocytes/macrophages (TAMs) are proposed to have significance in cancer. However, there is only limited data concerning their impact on patient outcome and survival in hepatocellular carcinoma (HCC). Methods: Frequencies of CD68
+ , CD163+ M2-polarized TAMs and TILs were measured in de novo HCC tumours in non-cirrhosis (n = 58) using immunohistology and correlated to patients' clinicopathological characteristics and survival rates. Results: Patients with tumours marked by appearance of TILs and CD68+ TAMs showed an improved 1-, 3- and 5-year recurrence-free survival (all p ≤ 0.05). CD68+ TAMs were associated with reduced incidence of recurrent and multifocal disease. Conversely, CD163+ TAMs were associated with multifocal HCC and lymphangiosis carcinomatosa (all p ≤ 0.05). Conclusions: TILs and CD68+ TAMs are associated with multiple tumour characteristics and patient survival in HCC. However, there is only scarce data about the biology underlying their mechanistic involvement in human tumour progression. Thus, experimental data on functional links might help develop novel immunologic checkpoint inhibitor targets for liver cancer. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
233. Loss of Msh2 and a single-radiation hit induce common, genome-wide, and persistent epigenetic changes in the intestine.
- Author
-
Herberg, Maria, Siebert, Susann, Quaas, Marianne, Thalheim, Torsten, Rother, Karen, Hussong, Michelle, Altmüller, Janine, Kerner, Christiane, Galle, Joerg, Schweiger, Michal R., and Aust, Gabriela
- Published
- 2019
- Full Text
- View/download PDF
234. Increased circulating chemerin in patients with advanced carotid stenosis.
- Author
-
Kammerer, Adrian, Staab, Holger, Herberg, Maria, Kerner, Christine, Klöting, Nora, Aust, Gabriela, and Klöting, Nora
- Subjects
CHEMERIN ,ADIPOKINES ,CAROTID artery stenosis ,C-reactive protein ,INFLAMMATION - Abstract
Background: Chemerin is an adipokine which plays a crucial role in atherosclerosis. Here, we examined whether circulating chemerin is enhanced in patients with advanced carotid stenosis.Methods: Chemerin was quantified in 178 patients prior to carotid end arterectomy (CEA) and in age- and gender-matched controls (n = 163). Chemerin levels were related to anthropometric, clinical and metabolic characteristics of the patients.Results: Chemerin levels were higher in patients compared to controls (p < 0.001). Chemerin correlated to parameters associated with inflammation such as C-reactive protein (CRP, p < 0.001), leukocyte blood count (p < 0.001) and circulating TNF-α (p = 0.004) in the patients. Chemerin levels did not differ between asymptomatic (n = 93) and symptomatic patients who experienced an ischemic event within 6 months prior to CEA (n = 85). However, in the case of high-grade carotid stenosis (≥ 90%), chemerin levels were higher in symptomatic (n = 44) compared to asymptomatic patients (n = 41, p = 0.014). Chemerin was increased in patients with (n = 50) compared to patients without (n = 128) coronary artery disease (CAD, p = 0.002). A high level of chemerin increases the risk for CAD in patients (p = 0.0013).Conclusions: Circulating chemerin is increased and correlates to inflammatory parameters in patients with advanced carotid stenosis. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
235. The Posttraumatic Increase in the Adhesion of GPCR EMR2/ ADGRE2 to Circulating Neutrophils Is Not Related to Injury Severity.
- Author
-
Zheng, Leyu, Rang, Moujie, Fuchs, Carolin, Keß, Annette, Wunsch, Mandy, Hentschel, Julia, Hsiao, Cheng-Chih, Kleber, Christian, Osterhoff, Georg, and Aust, Gabriela
- Subjects
- *
NEUTROPHILS , *G protein coupled receptors , *IMMUNE response - Abstract
Trauma triggers a rapid innate immune response to aid the clearance of damaged/necrotic cells and their released damage-associated molecular pattern (DAMP). Here, we monitored the expression of EMR2/ADGRE2, involved in the functional regulation of innate immune cells, on circulating neutrophils in very severely and moderately/severely injured patients up to 240 h after trauma. Notably, neutrophilic EMR2 showed a uniform, injury severity- and type of injury-independent posttraumatic course in all patients. The percentage of EMR2+ neutrophils and their EMR2 level increased and peaked 48 h after trauma. Afterwards, they declined and normalized in some, but not all, patients. Circulating EMR2+ compared to EMR2− neutrophils express less CD62L and more CD11c, a sign of activation. Neutrophilic EMR2 regulation was verified in vitro. Remarkably, it increased, depending on extracellular calcium, in controls as well. Cytokines, enhanced in patients immediately after trauma, and sera of patients did not further affect this neutrophilic EMR2 increase, whereas apoptosis induction disrupted it. Likely the damaged/necrotic cells/DAMPs, unavoidable during neutrophil culture, stimulate the neutrophilic EMR2 increase. In summary, the rapidly increased absolute number of neutrophils, especially present in very severely injured patients, together with upregulated neutrophilic EMR2, may expand our in vivo capacity to react to and finally clear damaged/necrotic cells/DAMPs after trauma. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
236. Correction: Winkler et al. The Adhesion G-Protein-Coupled Receptor GPR115/ ADGRF4 Regulates Epidermal Differentiation and Associates with Cytoskeletal KRT1. Cells 2022, 11 , 3151.
- Author
-
Winkler, Romy, Quaas, Marianne, Glasmacher, Stefan, Wolfrum, Uwe, Thalheim, Torsten, Galle, Jörg, Krohn, Knut, Magin, Thomas M., and Aust, Gabriela
- Subjects
- *
HORSERADISH peroxidase , *WESTERN immunoblotting ,KERATINOCYTE differentiation - Abstract
(f) The percentages of GPR115+ and KRT1/10+ cells were determined in these constructs built with HaCaT WT cells (n = 10 optical fields, n = 20-27 cells/field, means ± SEM). (c) Western blot analysis of lysates of HA-GPR115 Cos-7 cells treated with PNGase F (left) or of HA-GPR115 Cos-7 cells cultured with tunicamycin (right); the Abs used are indicated. (b) HaCaT WT cells and Cos-7 cells, transfected with GPR115 pcDNA3.1, were cell-surface-stained with the GPR115ECD Ab and analyzed by flow cytometry. [Extracted from the article]
- Published
- 2023
- Full Text
- View/download PDF
237. Free cholesterol, cholesterol precursor and plant sterol levels in atherosclerotic plaques are independently associated with symptomatic advanced carotid artery stenosis.
- Author
-
Ceglarek, Uta, Dittrich, Julia, Leopold, Jenny, Helmschrodt, Christin, Becker, Susen, Staab, Holger, Richter, Olaf, Rohm, Silvio, and Aust, Gabriela
- Subjects
- *
ATHEROSCLEROTIC plaque , *LIQUID chromatography-mass spectrometry , *CHOLESTEROL ,CAROTID artery stenosis - Abstract
Circulating sterols result either from cholesterol (CH) synthesis or intestinal uptake. They are mainly esterified and can be oxygenated. Sterols accumulate in atherosclerotic plaques whereby their clinical impact is uncertain. Here, we determined associations between circulating and plaque sterol levels in patients with advanced carotid artery stenosis in respect to a prior ischemic event and statin treatment. Free and esterified CH, CH precursors and plant sterols as well as oxysterols were quantified by liquid chromatography-tandem mass spectrometry in 63 consecutive patients undergoing carotid endarterectomy. CH, CH precursors, plant sterols and oxysterols accumulated in carotid artery plaques. Absolute circulating sterol levels were not predictive for their corresponding plaque levels. After normalisation to CH, plant sterol but not oxysterol levels correlated between plasma and plaques. Among the circulating sterols, oxysterols occurred proportionally less in plaques. Furthermore, CH and plant sterols were less esterified in plaques than in plasma. Patients who experienced a prior ischemic event (n = 29) and asymptomatic patients had, except for lanosterol, comparable circulating sterol levels. In contrast, the absolute plaque levels of free CH, CH precursors and plant sterols as well as oxysterols were increased in symptomatic compared to asymptomatic patients. These differences remained significant for free CH, precursors and 3 out of 4 analyzed plant sterols after adjustment to the most influencing covariates - statin treatment, type 2 diabetes and age. Increased absolute plaque levels of free CH, precursors and plant sterols predict an ischemic event in patients with advanced carotid artery stenosis. Image 1 • Carotid artery plaques contain cholesterol (CH), CH precursors, plant and oxysterols. • CH and plant sterols are less esterified in plaques than in plasma. • Plasma and plaque CH-normalized plant sterol but not oxysterol levels correlate. • Plaque sterol levels are higher in symptomatic compared with asymptomatic patients. • Plaque free CH, CH precursor and plant sterol levels predict an ischemic event. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
238. Angiogenic inflammation and formation of necrosis in the tumor microenvironment influence patient survival after radical surgery for de novo hepatocellular carcinoma in non-cirrhosis.
- Author
-
Atanasov, Georgi, Dino, Karoline, Schierle, Katrin, Dietel, Corinna, Aust, Gabriela, Pratschke, Johann, Seehofer, Daniel, Schmelzle, Moritz, and Hau, Hans-Michael
- Subjects
- *
HEPATOCELLULAR carcinoma , *TUMOR microenvironment , *NECROSIS , *TUMOR classification , *ANGIOPOIETINS - Abstract
Background: Tumor escape mechanisms mediated in the tumor microenvironment can significantly reduce the capacity of the anti-tumor function of the immune system. TIE2-expressing monocytes (TEMs), related angiopoietins, and tumor necrosis are considered to have a key role in this process. We aimed to investigate the abundance and clinical significance of these biomarkers in hepatocellular carcinoma (HCC). Methods: In this retrospective study, 58 HCC patients received surgery with a curative intent. The abundance of TEMs, angiopoietin-1 and -2 were detected in tumor specimens of the HCC patients (n = 58), and together with the occurrence of histologic tumor necrosis, were associated with established clinicopathological characteristics and survival. Results: Patients with HCC characterized by necrosis and TEMs revealed reduced both overall survival and recurrence-free survival (all p < 0.05). Angiopoietins and TEMs were associated with metastatic and recurrent HCC. Furthermore, the formation of histologic tumor necrosis was associated with advanced tumor stage and density of TEMs (all p < 0.05). Conclusions: Histologic tumor necrosis, TEMs, and related angiopoietins were associated with multiple HCC parameters and patient survival. The tumor necrosis–TEM–angiopoietin axis may offer a novel diagnostic modality to predict patient outcome after surgery for HCC. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
239. The expanding functional roles and signaling mechanisms of adhesion G protein-coupled receptors.
- Author
-
Morgan, Rory K., Anderson, Garret R., Araç, Demet, Aust, Gabriela, Balenga, Nariman, Boucard, Antony, Bridges, James P., Engel, Felix B., Formstone, Caroline J., Glitsch, Maike D., Gray, Ryan S., Hall, Randy A., Cheng-Chih Hsiao, Hee-Yong Kim, Knierim, Alexander B., Kusuluri, Deva Krupakar, Leon, Katherine, Liebscher, Ines, Xianhua Piao, and Prömel, Simone
- Subjects
- *
INTERLEUKIN-33 , *ADHESION , *G proteins - Abstract
The adhesion class of G protein-coupled receptors (GPCRs) is the second largest family of GPCRs (33 members in humans). Adhesion GPCRs (aGPCRs) are defined by a large extracellular N-terminal region that is linked to a C-terminal seven transmembrane (7TM) domain via aGPCR-autoproteolysis inducing (GAIN) domain containing a GPCR proteolytic site (GPS).Most aGPCRs undergo autoproteolysis at the GPS motif, but the cleaved fragments stay closely associated, with the N-terminal fragment (NTF) bound to the 7TMof the C-terminal fragment (CTF). The NTFs ofmost aGPCRs contain domains known to be involved in cell-cell adhesion, while the CTFs are involved in classical G protein signaling, as well as other intracellular signaling. In this workshop report, we review themost recent findings on the biology, signaling mechanisms, and physiological functions of aGPCRs. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
240. Linking stem cell function and growth pattern of intestinal organoids.
- Author
-
Thalheim, Torsten, Quaas, Marianne, Herberg, Maria, Braumann, Ulf-Dietrich, Kerner, Christiane, Loeffler, Markus, Aust, Gabriela, and Galle, Joerg
- Subjects
- *
STEM cells , *CELL growth , *ORGANOIDS , *INTESTINAL physiology , *CELL communication , *PHYSIOLOGY - Abstract
Intestinal stem cells (ISCs) require well-defined signals from their environment in order to carry out their specific functions. Most of these signals are provided by neighboring cells that form a stem cell niche, whose shape and cellular composition self-organize. Major features of this self-organization can be studied in ISC-derived organoid culture. In this system, manipulation of essential pathways of stem cell maintenance and differentiation results in well-described growth phenotypes. We here provide an individual cell-based model of intestinal organoids that enables a mechanistic explanation of the observed growth phenotypes. In simulation studies of the 3D structure of expanding organoids, we investigate interdependences between Wnt- and Notch-signaling which control the shape of the stem cell niche and, thus, the growth pattern of the organoids. Similar to in vitro experiments, changes of pathway activities alter the cellular composition of the organoids and, thereby, affect their shape. Exogenous Wnt enforces transitions from branched into a cyst-like growth pattern; known to occur spontaneously during long term organoid expansion. Based on our simulation results, we predict that the cyst-like pattern is associated with biomechanical changes of the cells which assign them a growth advantage. The results suggest ongoing stem cell adaptation to in vitro conditions during long term expansion by stabilizing Wnt-activity. Our study exemplifies the potential of individual cell-based modeling in unraveling links between molecular stem cell regulation and 3D growth of tissues. This kind of modeling combines experimental results in the fields of stem cell biology and cell biomechanics constituting a prerequisite for a better understanding of tissue regeneration as well as developmental processes. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
241. Glyphosate differentially affects the allergic immune response across generations in mice.
- Author
-
Buchenauer, Lisa, Junge, Kristin M., Haange, Sven-Bastiaan, Simon, Jan C., von Bergen, Martin, Hoh, Anna-Lena, Aust, Gabriela, Zenclussen, Ana C., Stangl, Gabriele I., and Polte, Tobias
- Published
- 2022
- Full Text
- View/download PDF
242. The Adhesion GPCR CD97/ADGRE5 inhibits apoptosis.
- Author
-
Hsiao, Cheng-Chih, Keysselt, Kerstin, Chen, Hsin-Yi, Sittig, Doreen, Hamann, Jörg, Lin, Hsi-Hsien, and Aust, Gabriela
- Subjects
- *
G protein coupled receptors , *APOPTOSIS inhibition , *CD antigens , *BCL-2 genes , *TUMOR necrosis factors , *STAUROSPORINE , *GENETIC overexpression - Abstract
The Adhesion G protein-coupled receptor (GPCR) CD97/ADGRE5 is induced, upregulated, and/or biochemically modified in various malignancies, compared to the corresponding normal tissues. As tumor cells are generally more resistant to apoptosis, we here studied the ability of CD97 to regulate tumor cell survival under apoptotic conditions. Stable overexpression of wild-type CD97 reduced serum starvation- and staurosporine-induced intrinsic and tumor necrosis factor (TNF)/cycloheximide-induced extrinsic apoptosis, indicated by an increase in cell viability, a lower percentage of cells within the subG0/G1 phase, expressing annexin V, or having condensed nuclei, and a reduction of DNA laddering. Protection from cell death by CD97 was accompanied by an inhibition of caspase activation and modulation of anti- and pro-apoptotic members of the BCL-2 superfamily. shRNA-mediated knockdown of CD97 and, in part, truncation of the seven-span transmembrane (TM7) region of CD97 increased caspase-mediated apoptosis. Protection from apoptosis required not only the TM7 region but also cleavage of the receptor at its GPCR proteolysis site (GPS), whereas alternative splicing of its extracellular domain had no effect. Together, our data indicate a role of CD97 in tumor cell survival. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
243. Fast LC–MS/MS analysis of free oxysterols derived from reactive oxygen species in human plasma and carotid plaque.
- Author
-
Helmschrodt, Christin, Becker, Susen, Schröter, Jenny, Hecht, Max, Aust, Gabriela, Thiery, Joachim, and Ceglarek, Uta
- Subjects
- *
LIQUID chromatography-mass spectrometry , *OXYSTEROLS , *REACTIVE oxygen species , *BLOOD plasma , *ATHEROSCLEROTIC plaque , *CHOLESTEROL - Abstract
Background: A rapid liquid chromatography–tandem mass spectrometric (LC–MS/MS) method was developed and validated for the quantification of reactive oxygen species (ROS) derived free oxysterols and cholesterol in human plasma and atherosclerotic plaque. Method: In vitro autoxidation of cholesterol during sample pretreatment was avoided by applying only one protein precipitation and re-concentration step using 80μl plasma. For preparation of 10mg atherosclerotic plaques an additional liquid–liquid extraction was included. Free 7-keto-, 7-α/ß-hydroxy-, 5,6-α-epoxy-, 5,6-β-epoxycholesterol, cholestane-3ß,5α,6ß-triol and cholesterol were separated within 7min on a monolithic column. An API 4000 tandem mass spectrometer was applied in positive ionization mode using atmospheric pressure chemical ionization. Results: The detection limit was 0.1ng/ml and the linearity ranged from 0.5 to 0.75 to 2000ng/ml for the oxysterols and from 50 to 1000μg/ml for cholesterol. Recovery was between 80.9 and 107.9%. Between-run imprecision ranged from 7.9 to 11.7%. Analysis of plasma samples from additional 50 middle-aged volunteers revealed a large inter-individual variability (e.g. 7-ketocholesterol 2.63-30.47ng/ml). Oxysterol concentrations normalized to cholesterol were about 43 times higher in carotid plaque compared to plasma (n=5). Conclusion: This rapid LC–MS/MS method enables reliable quantification focused on especially ROS-derived oxysterols in human plasma and atherosclerotic plaque samples under high-throughput conditions. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
244. Anatomija: 1500 slika, 3., prerađeno izdanje
- Author
-
Aumüller, Gerhard, Aust, Gabriela, and Engele, Jürgen et. al.
- Subjects
anatomija čovjeka ,udžbenik i atlas - Abstract
Anatomija Duale Reihe je daleko najbolji studentski udžbenik anatomije s kojim ćete se susresti. Spaja tradicionalni pristup sa zahtjevima da usvojeno znanje bude primjenjivo, ali istovremeno ne zanemaruje ni brojne važne anatomske detalje. Dijelovi teksta iz embriologije i mikroskopske anatomije koji se obrađuju nisu dodatno opterećenje podatcima, već su poveznica s makroskopskom anatomijom i omogućuju bolje funkcionalno razumijevanje. Udžbenik je bogato ilustriran, i to vrhunskim crtežima i fotografijama, pa izvrsno dopunjuje postojeće anatomske atlase.
- Published
- 2018
245. Signaltransduktion von CD97 in humanen Fibrosarkomzellen
- Author
-
Brosig, Susann, Aust, Gabriela, Schöneberg, Torsten, Engeland, Kurt, and Universität Leipzig
- Subjects
CD97, HT1080, Signaltransduktion ,ddc:610 ,CD97, HT1080, cell signaling pathways - Abstract
CD97 gehört zur Familie der Adhäsions-G-Protein gekoppelten Rezeptoren (aGPCR), die aus einem langen extrazellulären N-terminalen Fragment (NTF) und einem nicht-kovalent gekoppelten C-terminalen Fragment (CTF) mit der sieben-transmembranären (TM7) Region und dem intrazellulären Teil bestehen. CD97 wird in malignen Tumoren exprimiert. In der humanen Fibrosarkomzelllinie HT1080 steigert die stabile Überexpression von CD97 die ungerichtete zweidimensionale (2D) Migration einzelner Zellen. Eine Verkürzung von CD97 im CTF auf zwei transmembranäre (TM2) Domänen führt zu einer Suppression der 2D-Migration im Vergleich zu stabil mock-transfektierten HT1080 Kontrollzellen. Wahrscheinlich supprimiert CD97/TM2 die endogene CD97-Wirkung. Unbekannt ist, welche Signalwege durch CD97-Überexpression in HT1080 reguliert werden und welche Signalwege für die Migrationssteigerung von HT1080 verantwortlich sind. Die Klärung dieser Signalwege ist Gegenstand der vorliegenden Arbeit. Die Phosphorylierung von Proteinkinasen ist eine posttranslationale Modifikation zur Regulation der Kinaseaktivität mit nachfolgender Aktivierung oder Inaktivierung eines Signalweges. Daher sind Expression und Phosphorylierung der Proteinkinasen zur Identifikation regulierter Signalwege interessant. Dazu wurden in Lysaten von CD97/TM7, CD97/TM2 und mock-transfektierten HT1080 mittels Kinetworks Phosphosite Screen KPSS 1.3 Profiling (Multi-Immunoblot™) 37 verschiedene Proteinphosphorylierungen untersucht und regulierte Signalwege identifiziert. An 25 Phosphorylierungsstellen erfolgt eine Regulation durch CD97. Anschließend wurden die Ergebnisse der interessantesten Proteine hinsichtlich ihrer Expression und Phosphorylierung im Western Blot verifiziert und um Proteine erweitert, die klassisch an der Regulation der Zellmigration beteiligt sind. Es zeigt sich eine Aktivierung des PI3-Kinase/Akt-Signalweges und eine Inhibierung von Src durch CD97. 2D-Migrationsversuche von HT1080 CD97/TM7, CD97/TM2 und mock mit spezifischen Inhibitoren gegen den PI3-Kinase/Akt-Signalweg und gegen Src bestätigen, dass diese Kinasen an der CD97-induzierten Steigerung der 2D-Migration beteiligt sind. Weiterhin finden sich Hinweise, dass in HT1080 CD97 die Apoptose hemmt und die Proliferation reguliert. Insgesamt wird in dieser Arbeit ein Überblick über die durch CD97 regulierten Signalwege gegeben. Die CD97-gesteigerte 2D-Migration von HT1080 wird durch eine Aktivierung des PI3-Kinase/ Akt-Signalweges und Inhibierung von Src vermittelt.
- Published
- 2014
246. Funktionelle Relevanz intrazellulärer Splicevarianten des Brain-specific Angiogenesis Inhibitor 2 (BAI2): Funktionelle Relevanz intrazellulärer Splicevarianten des Brain-specific Angiogenesis Inhibitor 2 (BAI2)
- Author
-
Kiess, Alexandra, Schöneberg, Torsten, Aust, Gabriela, Gebhardt, Rolf, and Institut für Biochemie
- Subjects
Adhesion-GPCR, BAI2, GPCR, Splicevarianten, Calmodulin ,ddc:610 ,Adhesion-GPCR, BAI2, GPCR, splice variants, Calmodulin - Abstract
BAI2 gehört zu den Adhesion-G-Protein-gekoppelten Rezeptoren (aGPCR). Diese bisher wenig untersuchte Klasse von ca. 30 GPCR ist charakterisiert durch eine komplexe genomische Struktur, sehr große extrazelluläre Domänen und eine Vielzahl von Splicevarianten. Bisher ist bei den meisten aGPCR, wie auch bei BAI2, wenig über ihre Signaltransduktion und Funktion bekannt. Zum Verständnis der physiologischen Relevanz und zur Suche nach dem endogenen Agonist sind Kenntnisse über Proteinstruktur, Splicevarianten und Signaltransduktion essentiell. Ziel dieser Arbeit war es, mittels verschiedener in vitro-Methoden die Proteinstruktur des BAI2 in den transmembranären und intrazellulären Domänen näher zu untersuchen, sowie die natürlichen Splicevarianten in diesem Bereich, deren evolutionäre Konservierung, Gewebespezifität und Quantität zu erfassen. Für beide gefundenen Splicevarianten, eine im dritten intrazellulären Loop (ICL3) und eine im C-Terminus, konnte eine evolutionäre Konservierung auf Aminosäure- und genomischer Organisationsebene, sowie ihre Entstehung durch Exonskipping nachgewiesen werden. Nachfolgend wurden die Splicevarianten auf mögliche Interaktionen mit intrazellulären Komponenten untersucht. In dieser Arbeit konnte gezeigt werden, dass beide ICL3-Splicevarianten natürlicherweise in einem definierten Verhältnis auftreten. Außerdem konnte gezeigt werden, dass die lange ICL3-Variante des BAI2 nicht zu einer Änderung der Membrantopologie des Rezeptors, einer Homodimerisierung über die zusätzliche Aminosäuresequenz oder zu einer Interaktion mit dem C-Terminus führt. Die Splicevariante im humanen C-Terminus des BAI2 konnte als eine variable, durch Exonskipping entstandene Calcium-unabhängige Calmodulin-Bindungsstelle identifiziert werden. Diese Arbeit belegt die Existenz mehrerer BAI2-Isoformen in vivo. Die Struktur dieser Isoformen lässt unterschiedliche Funktionalitäten vermuten. Auch wenn erste Untersuchungen zwischen den beiden ICL3-Varianten keinen Unterschied ergaben, sind diese Erkenntnisse für die weitere Analyse der Signaltransduktion und Ligandensuche bedeutend. Es ist z.B. denkbar, dass sich die beiden ICL3-Varianten in der G-Protein-Kopplung oder bei der Rekrutierung von intrazellulären Interaktionspartnern unterscheiden oder dass die Splicevariante im C-Terminus zu einer Scaffold- Funktion des Calmodulins führt und/oder die Signaltransduktion durch eine permanente Bindung des Calmodulins an einer Isoform moduliert wird.
- Published
- 2014
247. Klonierung und Charakterisierung des murinen CD97 Promotors
- Author
-
Schubert-Hartmann, geb. Schubert, Andreas, Aust, Gabriela, Schöneberg, Torsten, and Universität Leipzig
- Subjects
CD97 ,ddc:610 ,CD97, Promotor, Genregulation - Abstract
CD97, ein Mitglied der Adhäsions-G-Protein-gekoppelten Rezeptoren (adhesion-GPCR), wird auf hämatopoetischen, muskulären und epithelialen Zellen exprimiert. Humanes und murines CD97 zeigen ein vergleichbares Expressionsmuster. Funktionell ist CD97 an Zell-Zell- und Zell-Matrix-Interaktionen, der Kanzerogenese und der Migration von Tumorzellen beteiligt. Um die molekulare Regulation von CD97 zu untersuchen, wurde der murine (m)CD97 Promotor charakterisiert. Unter verschiedenen murinen Zelllinien zeigten RAW264.7 (Makrophage), C2C12 (Myoblast) und C3H10T1/2 (Fibroblast) eine starke CD97 Expression. Der Transkriptionsstartpunkt des murinen (m)Cd97 Gens wurde -46bp upstream des ATG Startcodons lokalisiert. Es wurden Promotorplasmide hergestellt, welche aus verschieden langen Fragmenten der 5’ untranslatierten Region (5‘ UTR) von mCd97 und dem Reportervektor pGL3-Basic (pGL3) bestehen. Nach transienter Transfektion in die Zelllinien wurde mit einem Luziferasereportergenassay die Luziferaseaktivität bestimmt und damit der Nukleotidbereich -78 bis +29 bp der 5‘ UTR als minimaler Promotor definiert. Die evolutionär konservierten Nukleotide CACTT (-93/-89) konnten mittels Mutationsanalyse in den Zelllinien RAW264.7, C2C12 und C3H10T1/2 als aktivierende Sequenz im mCD97 Promotor identifiziert werden. Mit Hilfe vergleichender Bioinformatik und electrophoretic mobility shift assay (EMSA) gelang es nicht, den hier bindenden Transkriptionsfaktor zu bestimmen. In C2C12 zeigte die Differenzierung vom Myoblasten zum Myozyten eine Regulation von mCD97. Durch EMSA wurde in vitro die Bindung des serum response factor (SRF) an ein CArG-Element innerhalb der 5‘ UTR nachgewiesen. Zusammengefasst wurde der mCD97 Promotor erstmalig beschrieben und der Einfluss von SRF auf die mCD97 Expression in C2C12 nachgewiesen.
- Published
- 2013
248. Expression und Regulation von CD90 (Thy-1) auf makrovaskulären Endothelzellen
- Author
-
Uptaite, Migle, Aust, Gabriela, and Universität Leipzig
- Subjects
CD90, Thy-1, Atherosklerose, CXCL12 ,CD90, Thy-1, Atherosclerosis, CXCL12 ,ddc:610 - Abstract
Das humane CD90 (Thy-1), ein membrangebundenes Glykoprotein, wird auf der Oberfläche von aktivierten mikrovaskulären Endothelzellen (EC), Fibroblasten, Nervenzellen und einer Subpopulation von CD34+ hämatopoetischen Stammzellen exprimiert. CD90 fungiert als Adhäsionsmolekül auf aktivierten mikrovaskulären EC, indem es die Bindung von Leukozyten über die Interaktion mit dem Integrin alfambeta2 (Mac-1, CD11b/CD18) oder dem Adhäsions-GPCR CD97 an das Endothel vermittelt. Die Expression von CD90 auf mikrovaskulären EC wurde sowohl in-vitro als auch in-vivo nachgewiesen. Zur Expression von CD90 auf makrovaskulären EC gibt es nur wenige und sich zum Teil widersprechende in-vitro Daten. In-situ konnte die Expression von CD90 auf diesen Zellen bisher nicht gezeigt werden. Die Atherosklerose ist ein stufenweise verlaufendes chronisch-entzündliches Geschehen in den arteriellen Gefäßen. In der vorliegenden Arbeit wurde in atherosklerotisch-veränderten Gefäßen die Expression von CD90 auf humanen makrovaskulären EC in-situ demonstriert. Dabei wurden neben Operationspräparaten von Patienten mit einer Stenose der A. carotis interna, die entsprechend der American Heart Association Klassifikation die höchsten Atherosklerosestadien zeigen, auch Gefäßtransplantate von Organspendern, die meist nur eine geringe Ausprägung der Atherosklerose aufwiesen, untersucht. CD90 wurde in jedem Atherosklerosestadium auf EC nachgewiesen. Eine signifikante Zunahme der CD90 Expression in höheren Atherosklerosestadien konnte gezeigt werden. Die histologischen Merkmale der Plaque, wie Verkalkung, Blutung, Plaqueruptur oder Thrombusformation korrelieren nicht mit der CD90 Expression. Ein statistisch signifikanter Zusammenhang zwischen symptomatischer und asymptomatischer A.carotis interna-Stenose konnte bezüglich der CD90 Expression auf makrovaskulären EC ebenfalls nicht nachgewiesen werden. Weiterhin sollte mittels Stimulationsversuchen in-vitro geklärt werden, wie die CD90 Expression auf makrovaskulären EC im Rahmen der Atherosklerose auf den makrovaskulären EC reguliert wird. Denkbar ist, dass Zytokine, die eine Rolle im atherosklerotischen Prozess spielen, einen Einfluss auf die CD90 Expression ausüben. Deshalb wurde die Expression von CD90 auf makrovaskulären EC nach Stimulation mit proinflammatorischen Zytokinen untersucht. Die Expression von CD90 konnte in-vitro durch pro-inflammatorische Zytokine tendenziell erhöht werden. Die Stimulation mit CXCL12, einem bedeutsamen Trigger der Mobilisation der endothelialen Vorläuferzellen, der in atherosklerotischen, aber nicht in gesunden Gefäßen nachweisbar ist, bewirkte einen signifikanten Anstieg der CD90 Expression. Durch die Stimulation mit den lipid-beladenen Schaumzellen, die zahlreich in atherosklerotischen Läsionen vorhanden sind, konnte die CD90 Expression eher reduziert werden. Da Diabetes mellitus mit einem früheren Auftreten einer Atherosklerose assoziiert ist, wurden die makrovaskulären EC auch mit D-Glukose inkubiert. Dies führte ebenfalls zur tendenziellen Reduktion der CD90 Expression. Zusammenfassend konnte in der vorliegenden Arbeit die CD90-Expression auf den makrovaskulären EC in-situ eindeutig demonstriert werden. Im Rahmen der Atherosklerose nimmt CD90-Expression auf den makrovaskulären EC in den höheren Atherosklerosestadien zu. Eine tendenzielle Zunahme der CD90 Expression nach Stimulation mit proinflammatorischen Zytokinen, die an der Atheroskleroseentwicklung beteiligt sind, sowie eine signifikante Hochregulation der CD90 Expression nach Stimulation mit einem Trigger der EPC-Migration, dem CXCL12, konnte in dieser Arbeit gezeigt werden. Die Ergebnisse deuten auf eine wichtige Rolle des CD90 auf makrovaskulären EC in dem atherosklerotischen Prozess hin. Die publizierten Daten zeigen, dass CD90 in die Leukozytenmigration durch das aktivierte mikrovaskuläre Endothel involviert ist. In der vorliegenden Arbeit konnte jedoch nicht eindeutig nachgewiesen werden, welche Funktion das CD90 auf makrovaskulären EC besitzt. Hierbei ergaben sich zusammenfassend zwei an sich unterschiedliche Hypothesen. Zum einen zeigt die tendenzielle Zunahme der CD90-Expression nach Stimulation mit proinflammatorischen Zytokinen, dass CD90 an der Migration der neutrophilen Granulozyten und somit z.B. durch die Freisetzung von MMP-9 an der Destruktion der Plaque beteiligt sein kann. Zum anderen könnte man behaupten, dass die signifikante Hochregulation der CD90-Expression nach Stimulation mit dem CXCL12 auf die Beteiligung des CD90 an der EPC-Migration hindeutet. Somit könnte CD90 durch die EPC-Migration sowie z.B. zusätzlich durch die eingewanderten neutrophilen Granulozyten, welche den Zelldebris phagozytieren, in die Neointimaformation involviert sein. Um eine sichere Aussage diesbezüglich treffen zu können sind weitere Untersuchungen notwendig.
- Published
- 2012
249. Organoid Cultures In Silico: Tools or Toys?
- Author
-
Thalheim T, Aust G, and Galle J
- Abstract
The implementation of stem-cell-based organoid culture more than ten years ago started a development that created new avenues for diagnostic analyses and regenerative medicine. In parallel, computational modelling groups realized the potential of this culture system to support their theoretical approaches to study tissues in silico. These groups developed computational organoid models (COMs) that enabled testing consistency between cell biological data and developing theories of tissue self-organization. The models supported a mechanistic understanding of organoid growth and maturation and helped linking cell mechanics and tissue shape in general. What comes next? Can we use COMs as tools to complement the equipment of our biological and medical research? While these models already support experimental design, can they also quantitatively predict tissue behavior? Here, we review the current state of the art of COMs and discuss perspectives for their application.
- Published
- 2022
- Full Text
- View/download PDF
250. CDK7/12/13 inhibition targets an oscillating leukemia stem cell network and synergizes with venetoclax in acute myeloid leukemia.
- Author
-
He L, Arnold C, Thoma J, Rohde C, Kholmatov M, Garg S, Hsiao CC, Viol L, Zhang K, Sun R, Schmidt C, Janssen M, MacRae T, Huber K, Thiede C, Hébert J, Sauvageau G, Spratte J, Fluhr H, Aust G, Müller-Tidow C, Niehrs C, Pereira G, Hamann J, Tanaka M, Zaugg JB, and Pabst C
- Subjects
- Antineoplastic Combined Chemotherapy Protocols pharmacology, CDC2 Protein Kinase antagonists & inhibitors, Drug Synergism, Hedgehog Proteins metabolism, Hedgehog Proteins therapeutic use, Humans, Neoplastic Stem Cells drug effects, Neoplastic Stem Cells metabolism, Neoplastic Stem Cells pathology, Proto-Oncogene Proteins c-bcl-2 metabolism, Proto-Oncogene Proteins c-bcl-2 therapeutic use, Cyclin-Dependent Kinase-Activating Kinase, Bridged Bicyclo Compounds, Heterocyclic pharmacology, Cyclin-Dependent Kinases antagonists & inhibitors, Leukemia, Myeloid, Acute drug therapy, Leukemia, Myeloid, Acute metabolism, Leukemia, Myeloid, Acute pathology, Protein Kinase Inhibitors pharmacology, Sulfonamides pharmacology
- Abstract
The heterogeneous response of acute myeloid leukemia (AML) to current anti-leukemic therapies is only partially explained by mutational heterogeneity. We previously identified GPR56 as a surface marker associated with poor outcome across genetic groups, which characterizes two leukemia stem cell (LSC)-enriched compartments with different self-renewal capacities. How these compartments self-renew remained unclear. Here, we show that GPR56
+ LSC compartments are promoted in a complex network involving epithelial-to-mesenchymal transition (EMT) regulators besides Rho, Wnt, and Hedgehog (Hh) signaling. Unexpectedly, Wnt pathway inhibition increased the more immature, slowly cycling GPR56+ CD34+ fraction and Hh/EMT gene expression, while Wnt activation caused opposite effects. Our data suggest that the crucial role of GPR56 lies in its ability to co-activate these opposing signals, thus ensuring the constant supply of both LSC subsets. We show that CDK7 inhibitors suppress both LSC-enriched subsets in vivo and synergize with the Bcl-2 inhibitor venetoclax. Our data establish reciprocal transition between LSC compartments as a novel concept underlying the poor outcome in GPR56high AML and propose combined CDK7 and Bcl-2 inhibition as LSC-directed therapy in this disease., (©2022 The Authors. Published under the terms of the CC BY 4.0 license.)- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.